Companies being roped in to make the injectable drug
May 20, 2021
The Centre gives nod to five more drug companies to produce Amphotericin B
More domestic drugmakers have joined the brigade to produce Amphotericin B that is used to treat Mucormycosis (black fungus), and the shortages being reported in parts of the country are expected to ease in a fortnight.
The Centre has granted new drug approvals to five more drug companies for producing the injectable Amphotericin B in India, adding to the six companies that are already producing it. In fact, Union Minister of State for Chemicals Mansukh Mandaviya tweeted, “Black Fungus (Mucormycosis) curing drug #Amphotericin B’s shortage will be resolved soon!” Further, he added, “Indian companies have also placed orders for importing 6 lakh vials of Amphotericin B.”